高级检索
当前位置: 首页 > 详情页

GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 自然指数

机构: [1]Chinese Academy of Sciences (CAS) Key Laboratory of Innate Immunity and Chronic Disease, CAS Centre for Excellence in Cell and Molecular Biology,Innovation Centre for Cell Signalling Network, School of Life Sciences, University of Science and Technology of China, Hefei, China [2]Translational ResearchInstitute, Henan Provincial People’s Hospital, Zhengzhou, China [3]Department of Immunology, Anhui Medical University, Hefei, China [4]School of Medicineand Public Health, University of Newcastle, Callaghan, New South Wales, Australia [5]Department of Pathophysiology, School of Preclinical and ForensicMedicine, Sichuan University, Chengdu, China [6]School of Environmental and Life Sciences, University of Newcastle, Newcastle, New South Wales
出处:
ISSN:

摘要:
The list of long non-coding RNAs (lncRNAs) involved in the p53 pathway of the DNA damage response is rapidly expanding, but whether lncRNAs have a role in maintaining the de novo structure of DNA is unknown. Here, we demonstrate that the p53-responsive lncRNA GUARDIN is important for maintaining genomic integrity under steady-state conditions and after exposure to exogenous genotoxic stress. GUARDIN is necessary for preventing chromosome end-to-end fusion through maintaining the expression of telomeric repeat-binding factor 2 (TRF2) by sequestering microRNA-23a. Moreover, GUARDIN also sustains breast cancer 1 (BRCA1) stability by acting as an RNA scaffold to facilitate the heterodimerization of BRCA1 and BRCA1-associated RING domain protein 1 (BARD1). As such, GUARDIN silencing triggered apoptosis and senescence, enhanced cytotoxicity of additional genotoxic stress and inhibited cancer xenograft growth. Thus, GUARDIN may constitute a target for cancer treatment.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 1 区 生物
小类 | 1 区 细胞生物学
最新[2023]版:
大类 | 1 区 生物学
小类 | 1 区 细胞生物学
第一作者:
第一作者机构: [1]Chinese Academy of Sciences (CAS) Key Laboratory of Innate Immunity and Chronic Disease, CAS Centre for Excellence in Cell and Molecular Biology,Innovation Centre for Cell Signalling Network, School of Life Sciences, University of Science and Technology of China, Hefei, China [2]Translational ResearchInstitute, Henan Provincial People’s Hospital, Zhengzhou, China [3]Department of Immunology, Anhui Medical University, Hefei, China
共同第一作者:
通讯作者:
通讯机构: [1]Chinese Academy of Sciences (CAS) Key Laboratory of Innate Immunity and Chronic Disease, CAS Centre for Excellence in Cell and Molecular Biology,Innovation Centre for Cell Signalling Network, School of Life Sciences, University of Science and Technology of China, Hefei, China [2]Translational ResearchInstitute, Henan Provincial People’s Hospital, Zhengzhou, China [4]School of Medicineand Public Health, University of Newcastle, Callaghan, New South Wales, Australia
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号